Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Stock-Based Compensation of $1.63M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-29.92M |
|
-- |
|
-- |
|
$30.80M |
|
$-30.80M |
|
$0.90M |
|
$-29.90M |
|
$-29.90M |
|
$-29.92M |
|
$-29.92M |
|
$-29.92M |
|
$-29.92M |
|
$-30.80M |
|
$-30.80M |
|
33.15M |
|
33.15M |
|
$-0.90 |
|
$-0.90 |
|
| Balance Sheet Financials | |
$14.68M |
|
-- |
|
$0.82M |
|
$15.50M |
|
$14.60M |
|
-- |
|
$0.09M |
|
$14.69M |
|
$0.81M |
|
$0.81M |
|
$0.81M |
|
46.58M |
|
| Cash Flow Statement Financials | |
$-33.54M |
|
-- |
|
$23.65M |
|
$23.37M |
|
$13.48M |
|
$-9.89M |
|
|
Stock-Based Compensation |
$1.63M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.01 |
|
-- |
|
-- |
|
-- |
|
0.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3682.04% |
|
-3681.99% |
|
-192.99% |
|
-3681.99% |
|
$0.02 |
|
$-1.01 |
|
$-1.01 |
|